20 results
8-K
EX-99.1
IMUX
Immunic Inc
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
, the European Union’s research and innovation program for 2014-2020
Luxembourg, Gräfelfing, Germany and New York, October 20, 2020 – The European … better control the pandemic,” said Ambroise Fayolle, EIB Vice-President in charge of innovation and lending in Germany. “The role of European
8-K
EX-99.1
IMUX
Immunic Inc
27 Apr 23
Departure of Directors or Certain Officers
6:40am
at Biogen as Director of the Value-Based Medicine Innovation Hub and Director of the Medical Evidence, Research and Innovation Unit. He has authored over
424B3
IMUX
Immunic Inc
30 Apr 24
Prospectus supplement
5:16pm
Janus Henderson Biotech Innovation Master Fund Limited8
Soleus Private Equity Fund III, L.P.9
Soleus Capital Master Fund, LP10
Altium Growth Fund … -funded warrants held in the aggregate by RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., and RTW Biotech Opportunities Ltd (the “RTW Funds
425
f49n1fl192r1kl875
7 Jan 19
Business combination disclosure
4:41pm
424B4
c8lhf8losllby 60
17 Apr 14
Prospectus supplement with pricing info
12:00am
424B3
r0dpq3nt i0l
20 Dec 22
Prospectus supplement
5:01pm
10-K
e9nh0z0vxdhecga
20 Mar 15
Annual report
12:00am
424B4
tgbnr570k58pi
3 Oct 14
Prospectus supplement with pricing info
12:00am
DEF 14A
h38irkv3bt0d
7 Oct 15
Definitive proxy
12:00am
424B3
jma30j
19 Feb 19
Prospectus supplement
5:03pm
S-4/A
2ytyjkg a3q19tzceplu
14 Feb 19
Registration of securities issued in business combination transactions (amended)
9:02am
S-4
gqyyh0
4 Feb 19
Registration of securities issued in business combination transactions
5:58pm
- Prev
- 1
- Next